UCL’s life sciences expertise showcased at London Life Sciences Week
Spinouts pitched their healthcare innovations to a global community of investors.
Entrepreneurs from early-stage spinouts across London’s universities came together for the New Frontiers Showcase on 18 November, providing an opportunity to pitch their innovations to the investment community and celebrate the capital’s strength in life sciences.
The showcase explored three major trends shaping the sector: London’s ability to turn scientific discovery into commercial success, its position at the forefront of AI-driven life sciences innovation, and the role of the city’s specialised innovation clusters in supporting growth.
Representing UCL were two spinouts developing technologies with the potential to improve the diagnosis and treatment of patients:
- Eye2Gene has created an AI-powered precision ophthalmology platform, combining imaging and genomics to help eye care professionals speed up the diagnosis of inherited retinal diseases, getting sight-saving treatments to patients earlier.
- Echopoint Medical Ltd is developing fibre optic-based microcathers to provide a complete picture of heart physiology, helping clinicians make quicker and better-informed cardiovascular treatment decisions.
UCL Ventures’ CEO, Dr Anne Lane, also contributed to the event, sharing her insights in a keynote address. She reflected on the importance of bringing together researchers, entrepreneurs and investors to help promising life sciences innovations progress towards real-world impact.
Dr Lane commented: “London has an extraordinary life sciences ecosystem, bringing together world-leading research, entrepreneurial talent and an active investment community. Events like London Life Sciences Week give us an important opportunity to celebrate that strength and, crucially, to connect promising new ventures with the people who can help them grow. It was fantastic to see UCL spinouts showcasing how research and innovation can be translated into technologies with the potential to make a real difference to patients.”
Over 300 investors from around the world signed up to attend the New Frontiers showcase from leading companies including Albion, Barclays Innovation Banking, Mishcon De Reya, Twinpath Ventures and Corallia Ventures.
The event built on the success of a similar showcase during 2025 London Life Sciences Week, at which newly-formed UCL spinout BiotaLife presented. Since then, Biotalife has gone on to refocus its business plan and developed and launched its first consumer product ‘Bloomcalma’ - a specialist microbiome-friendly intimate moisturiser designed for women to use in both pregnancy and following childbirth.